Poop pills could reboot cancer fight in lung patients
NCT ID NCT07432984
First seen Mar 10, 2026 · Last updated Jun 09, 2026 · Updated 13 times
Summary
This study tests whether a fecal microbiota transplant (FMT) — transferring healthy gut bacteria from a donor — can help the immune system fight advanced non-small cell lung cancer again in people whose cancer stopped responding to standard immunotherapy. About 15 adults will receive FMT along with the drug tislelizumab. The goal is to see if this combination is safe and can shrink tumors or slow the disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NON-SMALL CELL LUNG CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.